OUR APPROACH
The idea is to develop breakthrough technologies no matter where they come from geographically. NXT has already started investing in intellectual property, and seeks to output biomedical startups as we complete early feasibility.
MEET THE TEAM
It takes a lifetime of experimentation, study of medical literature and procedures, and investment in novel solutions to equip a team capable of developing breakthrough ideas into promising commercial products. The ambitions of NTX Biomedical are born in these committed medical device innovators. Meet the minds behind this platform for innovation.
Stanton Rowe
Founder & CEO
Mr. Stanton J. Rowe, also known as Stan, now CEO of the NXT Biomedical Incubator has been the Chief Scientific Officer of Edwards Lifesciences Corp. since 2008 and serves as its Corporate Vice President of Advanced Technology. Mr. Rowe served as a Scientific Advisor at Ascent Biomedical Ventures. He Founded Percutaneous Valve Technologies (sold to Edwards).
Mr. Rowe served as the President and Chief Executive Officer of Percutaneous Valve Technologies Inc. (PVT). He served as the Corporate Vice President of Business Development and Strategic Planning at Datascope Corp. Prior to this, Mr. Rowe served as a Vice President of Business Development at Johnson & Johnson’s Interventional Systems Division (JJIS), responsible for Johnson & Johnson’s coronary stent development efforts. At JJIS and the related Cordis Corporation, he held a variety of positions with increasing levels of responsibility, including heading Johnson & Johnson’s Business Development, Advanced Technology, Worldwide Clinical Research and Marketing groups. Mr. Rowe joined Cordis after having held several positions in product management for various medical device companies.
He serves as a Director of InSeal Medical Ltd. Mr. Rowe also serves as Director of Remon Medical Ltd. He serves as a Board Member of NeuralAnalytics and the Discovery Science Center in Orange County. He serves as a Director of Zift Medical, LLC. He served as a Director of Biomerix Corporation. He holds a Bachelor’s Degree from the University of Alabama.
DR. ROBERT SCHWARTZ, M.D. FACC, FAHA, FSCCT
Co-Founder
Dr. Schwartz grew up in Boulder, Colorado, enjoying and thriving in the academic community surrounding the University of Colorado. He is driven by a lifelong passion of understanding how things work and developing new technologies for medical application. He holds undergraduate and graduate degrees in Physics, Electrical Engineering, and Biomedical Engineering.
He entered medical school with the goal to combine basic science, medical device technology, and clinical Cardiovascular practice. He completed post graduate medical residencies and Fellowships in Internal Medicine and Cardiology at Mayo Clinic in Rochester, MN. After serving four years as a US Air Force Flight Surgeon, he accepted a Staff position in Cardiovascular Diseases at Mayo Clinic, and established the Mayo Center for Applied Vascular Biology and Coronary Interventions. While in this role he was honored with the prestigious, Andreas Gruentzig Basic Research Award, given by the European Society of Cardiology.
To expand his involvement with the medtech/biotech community, he joined the Minneapolis Heart Institute in 2002 as clinician and Researcher, and founded the Minnesota Cardiovascular Research Institute. This institute is dedicated to novel technology and its medical applications. He currently practices Clinical Cardiology and is passionate about its interface with technology.
Dr. Schwartz has authored or co-authored more than 500 scientific publications and abstracts. He lectures extensively (Nationally and internationally), and is a named inventor on more than 60 patents in medical devices and technology. He has co-founded several successful medical device companies, and enjoys consulting in the Medical Device Industry, Venture Capital, and the FDA.